Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/2 study evaluating safety, tolerability, and activity of a new phosphate binder SBR759 in chronic kidney disease patients on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• SBR759

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Kidney Disease | Phase 1, Phase 2 | Status: COMPLETED